Clarivate Plc (CLVT)
| Market Cap | 1.50B -34.9% |
| Revenue (ttm) | 2.38B +7.7% |
| Net Income | -386.50M |
| EPS | -0.60 |
| Shares Out | 639.90M |
| PE Ratio | n/a |
| Forward PE | 3.48 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,686,292 |
| Open | 2.270 |
| Previous Close | 2.330 |
| Day's Range | 2.240 - 2.405 |
| 52-Week Range | 1.420 - 3.870 |
| Beta | 1.39 |
| Analysts | Hold |
| Price Target | 3.00 (+28.21%) |
| Earnings Date | Nov 3, 2026 |
About CLVT
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library service... [Read more]
Financial Performance
In 2025, Clarivate's revenue was $2.46 billion, a decrease of -3.97% compared to the previous year's $2.56 billion. Losses were -$201.10 million, -69.90% less than in 2024.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for CLVT stock is "Hold." The 12-month stock price target is $3.0, which is an increase of 28.21% from the latest price.
News
Clarivate price target lowered to $2.30 from $2.60 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Clarivate (CLVT) to $2.30 from $2.60 and keeps a Neutral rating on the shares.
Clarivate Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Nov. 4, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Sci...
Clarivate Earnings Call Transcript: Q3 2026
The divestiture sharpens the portfolio around two recurring-revenue segments, with Q3 organic ACV and recurring revenue growth improving. FY26 guidance anticipates stronger Q4 growth, expanding margins, and continued debt reduction.
Clarivate Slides: Q3 2026
Clarivate has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
Clarivate Quarterly report: Q3 2026
Clarivate has published its Q3 2026 quarterly earnings report on November 3, 2026.
Clarivate Earnings release: Q3 2026
Clarivate released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
Clarivate narrows FY26 adjusted EPS view to 73c-77c from 70c-80c
Consensus 72c. Cuts FY26 revenue view to $1.97B-$1.99B from $2.3B-$2.4B, consensus $2.21B. Cuts FY26 adjusted EBITDA view to $865M-$885M from $980M-$1.04B. The company said, “The full year 2026 outloo...
Clarivate reports Q3 adjusted EPS 21c, consensus 18c
Reports Q3 revenue $481.6M, consensus $490.1M. The company said, “Third quarter results continued to improve across key metrics, including organic recurring revenue growth and the return to positive A...
Clarivate sees Q4 adjusted EPS 14c-18c, consensus 18c
Sees Q4 revenue $490M-$510M, consensus $502.35M. Sees Q4 adjusted EBITDA $215M-$235M. The company said, “We are seeing the benefits of disciplined execution across the business, with improving growth ...
Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation
— Improved recurring organic revenue growth driven by portfolio transformation and AI-led innovation — — Updates 2026 financial outlook following the divestiture of Life Sciences & Healthcare segment...
Clarivate to Bring Trusted Trademark Data into Microsoft Copilot Through IPOne
LONDON, Nov. 2, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced it will bring trusted CompuMark trademark data and insights in...
Clarivate resumed with an Underweight at Morgan Stanley
Morgan Stanley analyst Toni Kaplan resumed coverage of Clarivate (CLVT) with an Underweight rating and $1.50 price target The firm expects organic growth to remain modest and below peers, leading…
Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence
More than 100 institutions across 25 countries and regions are using the AI-native research intelligence platform. LONDON, Oct. 22, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global pr...
Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions
WASHINGTON--(BUSINESS WIRE)--Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (N...
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments Proceeds strengthen balance sheet and enhance financial flexibility LONDON, Oct. 6, 2026 /PRNew...
Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previ...
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (...
Clarivate to Report Third Quarter 2026 Results on November 3, 2026
LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for th...
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate...
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading...
Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member
Veteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise to Support Accuserve's Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 ...
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LON...
Clarivate price target lowered to $5 from $6 at Stifel
Stifel lowered the firm’s price target on Clarivate (CLVT) to $5 from $6 and keeps a Buy rating on the shares.
Clarivate price target lowered to $2.50 from $2.80 at Citi
Citi analyst Peter Christiansen lowered the firm’s price target on Clarivate (CLVT) to $2.50 from $2.80 and keeps a Neutral rating on the shares.
Clarivate price target lowered to $2.60 from $2.90 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Clarivate (CLVT) to $2.60 from $2.90 and keeps a Buy rating on the shares.